Difference between revisions of "Education"

From QIBA Wiki
Jump to navigation Jump to search
 
(127 intermediate revisions by 3 users not shown)
Line 1: Line 1:
  
==QIBA Newsletter==
+
==QIBA in the Literature Citations==
::[[Image:QIBA_mastheader.jpg|300px]]
+
RSNA staff maintains a QIBA citation library in EndNote. Scientific journals featuring QIBA projects or articles that may reference QIBA and its efforts are included.  
:*'''http://www.rsna.org/QIBA-Newsletters/'''
+
 
* [https://tinyurl.com/QIBA-in-the-Literature QIBA in the Literature]
+
Articles are divided into three categories:
 +
* Generated by QIBA research teams
 +
* References QIBA
 +
* Metrology Publications
 +
 
 +
===='''Instructions:'''====
 +
All QIBA leaders have been automatically provided access to the collections and anyone else will be given access upon request. If you already have an EndNote account: please [https://access.clarivate.com/login?app=endnote '''log in'''] to view the collections. All three QIBA citation groups should appear under, “Groups Shared by Others.”
  
[[File:
+
If you do not already have an EndNote account: you can register for the free, web-based version called [https://access.clarivate.com/login?app=endnote '''EndNote Basic''']. If additional assistance is needed in gaining access to the collections please send an email to: [mailto:qiba@rsna.org?Subject=URL%20Encoded%20Subject&body=Body%20Text '''QIBA staff'''].
<iframe src="https://docs.google.com/document/d/e/2PACX-1vQUccFXf4-LkmpNJ4u-CI57DFnlGDaDnDaXVqc8qZZDQjd6_OlxipGb9AQTWdBLGhd8ZM3p-m6x1KQj/pub?embedded=true"></iframe>]]
 
 
::Welcome to the ''QIBA Newsletter'', an e-newsletter dedicated to providing news and information from the Quantitative Imaging Biomarkers Alliance (QIBA), formed by RSNA in 2007 to unite researchers, healthcare professionals, and industry stakeholders in the advancement of quantitative imaging and the use of biomarkers in clinical trials and practice. The ''QIBA Newsletter'' offers articles, web links and tools, as well as updates from technical committees and information about how you can participate in QIBA activities.
 
  
==QIBA in the Literature Citations==
 
This document houses citations from scientific journals featuring QIBA projects or articles that may reference QIBA and its efforts.
 
*'''[[Media:QIBA_in_the_literature_(updated 01 22 2018).pdf|QIBA Literature References]]'''
 
  
Articles are divided into two categories:
+
==U.S. Food and Drug Administration (FDA) Guidance==
* Articles that are generated by QIBA research teams
+
The Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket
* Articles that reference QIBA
+
Submissions Guidance for Industry and Food and Drug Administration Staff was released on June 16, 2022, and can be accessed at this link or via the PDF below:
 +
 
 +
*https://www.fda.gov/regulatory-information/search-fda-guidance-documents/technical-performance-assessment-quantitative-imaging-radiological-device-premarket-submissions
 +
 
 +
This guidance document provides FDA's recommendations on the information, technical performance assessment, and user information that should be included in a premarket submission for radiological devices that include quantitative imaging functions. The recommendations reflect current review practices and are intended to promote consistency and facilitate efficient review of premarket submissions for radiological devices that include quantitative imaging functions.
  
If available, links are provided to '''http://www.PubMed.gov''' or to journal landing pages.
+
*[[Media:06 16 2022 FDA Guidance.pdf | Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket ]] (June 16, 2022)
  
 +
==QIBA Historical Initiative==
  
==QIBA News==
+
:[[Image:Cancer Moonshot.jpg|120px]]
  
::[[Image:Cancer Moonshot.jpg|120px]]
 
  
 
'''Cancer Moonshot & QIBA''' [https://medium.com/cancer-moonshot]
 
'''Cancer Moonshot & QIBA''' [https://medium.com/cancer-moonshot]
Line 29: Line 33:
 
*The FDG-PET/CT and CT Volumetry Profiles have been submitted as the most advanced Profiles to-date.  Our sincerest appreciation to all of the QIBA participants who helped us arrive at this important milestone.
 
*The FDG-PET/CT and CT Volumetry Profiles have been submitted as the most advanced Profiles to-date.  Our sincerest appreciation to all of the QIBA participants who helped us arrive at this important milestone.
  
 +
==Biomarker Status Update Posters==
  
==Biomarker Status Update Posters==
+
*[[QIBA posters from RSNA 2019 Annual Meeting|RSNA 2019 Posters]]
  
*[[QIBA posters from RSNA 2017 Annual Meeting|RSNA 2017 Posters]]
+
'''''[[QIBA Posters from RSNA Annual Meetings Archive]]'''''
*[[QIBA posters from RSNA 2016 Annual Meeting|RSNA 2016 Posters]]
 
*[[QIBA posters from RSNA 2015 Annual Meeting|RSNA 2015 Posters]]
 
*[[QIBA posters from RSNA 2014 Annual Meeting|RSNA 2014 Posters]]
 
*[[QIBA posters from RSNA 2013 Annual Meeting|RSNA 2013 Posters]]
 
*[[QIBA posters from RSNA 2012 Annual Meeting|RSNA 2012 Posters]]
 
*[[QIBA posters and plenary session presentation from RSNA 2011 Annual Meeting|RSNA 2011 Posters]]
 
*[[QIBA and UPICT posters from RSNA 2010 Annual Meeting|RSNA 2010 Posters]]
 
*[[QIBA and UPICT posters from RSNA 2009 Annual Meeting|RSNA 2009 Posters]]
 
*[[Media:FREEMAN_FINAL_PROOF.pdf|RSNA 2008 Posters]]
 
  
  
 
==QIBA Special Interest Sessions at the RSNA Scientific Assembly and Annual Meeting==
 
==QIBA Special Interest Sessions at the RSNA Scientific Assembly and Annual Meeting==
  
 +
'''2018'''
 +
 +
*[https://s3.amazonaws.com/east1.public.rsna.org/qiba/SPSI21-2018.mp4 RSNA 2018 Special Interest Session: Quantitative Imaging Applications in Screening, Treatment Selection, and Treatment Assessment - The Need for Standardization in the Era of Personalized Medicine, Edward F. Jackson, PhD] - November 26, 2018
 
'''2016'''
 
'''2016'''
  
Line 58: Line 57:
  
 
==Presentations==
 
==Presentations==
 +
 +
'''2018'''
 +
 +
*[[Media:Conformance Assessment Introduction.pdf | Conformance Assessment Introduction (Nancy Obuchowski, PhD)]] - November 28, 2018
 +
*[[Media:Transitioning QIBs into Clinical Trials.pdf | Transitioning QIBs into Clinical Trials: Practical Implementation Requirements (Nancy Obuchowski, PhD)]] - November 28, 2018
 +
 
'''2017'''
 
'''2017'''
 
*[https://uwmadison.box.com/s/0v65bikqqi0eighle6pbfz9zahtysqwo An Overview of the Quantitative Imaging Biomarkers Alliance (QIBA®)]- February 8, 2017
 
  
 
*[[Media:QDET demonstration 20170119.pdf | Round-5 Cross-modality Project: QDET Demonstration]] - January 19, 2017
 
*[[Media:QDET demonstration 20170119.pdf | Round-5 Cross-modality Project: QDET Demonstration]] - January 19, 2017
Line 68: Line 71:
 
<font color=green>'''Google Chrome''' or '''Firefox''' browsers are recommended for viewing these PowerPoint presentations.</font>
 
<font color=green>'''Google Chrome''' or '''Firefox''' browsers are recommended for viewing these PowerPoint presentations.</font>
 
*[[Media:QIBA_Process_and_Metrology-2016.11.18v2-ODonnell.pptx| RSNA2016 QIBA Session - Part II - Process and Metrology]] - Nov 2016
 
*[[Media:QIBA_Process_and_Metrology-2016.11.18v2-ODonnell.pptx| RSNA2016 QIBA Session - Part II - Process and Metrology]] - Nov 2016
*[[Media:QIBA Intro-2016.07.22.2016-Part I.pptx | Introduction to the Quantitative Imaging Biomarkers Alliance - Part I {QIBA ®}]] - July 22, 2016
+
*[[Media:QIBA Intro-2016.07.22.2016.pdf | Introduction to the Quantitative Imaging Biomarkers Alliance {QIBA ®}]] - July 22, 2016  
*[[Media:QIBA Intro-2016.07.22.2016-Part II-b.pptx | Introduction to the Quantitative Imaging Biomarkers Alliance - Part II {QIBA ®}]] - July 22, 2016
 
 
*[[Media:QIBA_Expectations_for_Japan_Activities-2016.04.u.pptx|QIBA Expectations for Japan Activities]] - April 17, 2016 JRS Conference, Yokohama, Japan
 
*[[Media:QIBA_Expectations_for_Japan_Activities-2016.04.u.pptx|QIBA Expectations for Japan Activities]] - April 17, 2016 JRS Conference, Yokohama, Japan
 
* [http://www2.rsna.org/re/QIBA_Annual_Meeting_2016 2016 QIBA Annual Meeting Presentations] - April 13-14, 2016 Alexandria, VA
 
* [http://www2.rsna.org/re/QIBA_Annual_Meeting_2016 2016 QIBA Annual Meeting Presentations] - April 13-14, 2016 Alexandria, VA

Latest revision as of 15:13, 17 June 2022

QIBA in the Literature Citations

RSNA staff maintains a QIBA citation library in EndNote. Scientific journals featuring QIBA projects or articles that may reference QIBA and its efforts are included.

Articles are divided into three categories:

  • Generated by QIBA research teams
  • References QIBA
  • Metrology Publications

Instructions:

All QIBA leaders have been automatically provided access to the collections and anyone else will be given access upon request. If you already have an EndNote account: please log in to view the collections. All three QIBA citation groups should appear under, “Groups Shared by Others.”

If you do not already have an EndNote account: you can register for the free, web-based version called EndNote Basic. If additional assistance is needed in gaining access to the collections please send an email to: QIBA staff.


U.S. Food and Drug Administration (FDA) Guidance

The Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket Submissions Guidance for Industry and Food and Drug Administration Staff was released on June 16, 2022, and can be accessed at this link or via the PDF below:

This guidance document provides FDA's recommendations on the information, technical performance assessment, and user information that should be included in a premarket submission for radiological devices that include quantitative imaging functions. The recommendations reflect current review practices and are intended to promote consistency and facilitate efficient review of premarket submissions for radiological devices that include quantitative imaging functions.

QIBA Historical Initiative

Cancer Moonshot.jpg


Cancer Moonshot & QIBA [1]

  • RSNA/QIBA is very pleased to announce that two of the QIBA Profiles relevant to cancer patients have been referenced and supported by the Federal Cancer Moonshot Initiative (https://medium.com/cancer-moonshot) as ways to advance research and outcomes.
  • The FDG-PET/CT and CT Volumetry Profiles have been submitted as the most advanced Profiles to-date. Our sincerest appreciation to all of the QIBA participants who helped us arrive at this important milestone.

Biomarker Status Update Posters

QIBA Posters from RSNA Annual Meetings Archive


QIBA Special Interest Sessions at the RSNA Scientific Assembly and Annual Meeting

2018

2016


Presentations

2018

2017

2016

Google Chrome or Firefox browsers are recommended for viewing these PowerPoint presentations.

2015

2014

2010

2009

Consider also organizing or tagging presentations by topic?